Nabriva Therapeutics Plc

NASDAQ:NBRV   3:12:41 PM EDT
1.50
-0.10 (-6.25%)
Earnings Announcements

Nabriva Therapeutics Posts Qtrly Loss Per Share $1.11

Published: 03/11/2021 23:10 GMT
Nabriva Therapeutics Plc (NBRV) - Quarterly Revenue $2.5 Million Versus $300,000.
Qtrly Loss per Share $1.11.
Revenue is expected to be $2 Million
Adjusted EPS is expected to be -$0.57

Next Quarter Revenue Guidance is expected to be $7.25 Million
Next Quarter EPS Guidance is expected to be -$0.41

More details on our Analysts Page.